Home > Research Institute > Available Trials > Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I) (01-PS-001)
Disease Types: Breast
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I) (01-PS-001)
For More Information:
https://clinicaltrials.gov/study/NCT06230185?term=%20(B-STRONGER-I)%20(01-PS-001)&rank=1